Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

Hugh Grosvenor, The Duke of Westminster, has donated £1m towards Oxford University’s COVID-19 mental health research programmes. This is part of the £10m donation announced by the Westminster Foundation last month to support the national COVID-19 relief effort.

Teenage girl sad and thoughtful looking out of a window

The grant will be made available through the Westminster Foundation to support the University’s Department of Psychiatry, which is at the forefront of mental health research in the UK. They are addressing a broad range of mental health issues arising from the pandemic and its impacts on the human psyche, including isolation, confinement, uncertainty, anxiety, stress and the disconnection from our social, family and work lives.

The effect of the pandemic on the mental well-being of children is of particular concern and interest to the Duke, and Westminster Foundation, which provides long-term support to vulnerable young people and families.

The University’s mental health researchers are developing diagnostic tools and crafting expert guidance for governments, schools, parents, medical professionals, therapists, carers and individuals. For example, Oxford is working with thousands of local families to track children and young people’s mental health throughout the COVID-19 crisis. The results will help researchers identify what protects children and young people from deteriorating mental health over time and at particular stress points, and how this may vary according to child and family characteristics. A team of psychiatrists and researchers are also developing a set of resources to help communicate parental illness and death to children.

Read the full story on the University of Oxford website

Similar stories

General anaesthesia should be available for dying patients - medical and ethical experts

General Research

General anaesthesia should be more widely available for patients at the end of their lives, according to Oxford experts in ethics and anaesthesia, according to a paper published by Anaesthesia (a journal of the Association of Anaesthetists).

Human challenge trial launches to study immune response to COVID-19

Clinical Trials Coronavirus COVID-19 General

Though the COVID-19 pandemic has now been active for a year, not much is known about what happens when people who have already had COVID-19 are infected for a second time.

Risk of rare blood clotting higher for COVID-19 than for vaccines

Coronavirus COVID-19 Research

COVID-19 leads to a several-times higher risk of cerebral venous thrombosis (CVT) blood clots than current COVID-19 vaccines.

Alternating vaccines trial expands to include two additional vaccines

Clinical Trials Coronavirus COVID-19 General

Researchers running the Com-Cov study, launched in February to investigate alternating doses of the Oxford-AstraZeneca vaccine and the Pfizer vaccine, have today announced that the programme will be extended to include the Moderna and Novavax vaccines in a new study.

Oxford medical students launch flagship raffle in aid of NHS heroes and lifesaving medical equipment

General

Tingewick, a society formed of medical students from Oxford University, are hosting a virtual charity raffle. With over 70 amazing prizes, ranging from Truck festival tickets to restaurant vouchers to bags of books and even a bike, the raffle is an exciting way to celebrate lockdown lifting by supporting many wonderful Oxfordshire businesses whilst raising lots of money for charity.